atazanavir teva 200 mg
teva israel ltd - atazanavir as sulfate - capsules - atazanavir as sulfate 200 mg - atazanavir - atazanavir teva ® is indicated in combination with other antiretroviral agents for for the treatment of hiv-1 infection.
atazanavir teva 300 mg
teva israel ltd - atazanavir as sulfate - capsules - atazanavir as sulfate 300 mg - atazanavir - atazanavir teva ® is indicated in combination with other antiretroviral agents for for the treatment of hiv-1 infection.
atazanavir teva 150 mg
teva israel ltd - atazanavir as sulfate - capsules - atazanavir as sulfate 150 mg - atazanavir - atazanavir teva ® is indicated in combination with other antiretroviral agents for for the treatment of hiv-1 infection.
atazanavir viatris
viatris limited - atazanavir sulfate 170.85mg equivalent to atazanavir 150mg; atazanavir sulfate 170.85mg equivalent to atazanavir 150mg - capsule - 150 mg - active: atazanavir sulfate 170.85mg equivalent to atazanavir 150mg excipient: crospovidone gelatin iron oxide red lactose monohydrate magnesium stearate patent blue v purified water tekprint black sw-9008 titanium dioxide active: atazanavir sulfate 170.85mg equivalent to atazanavir 150mg excipient: brilliant blue fcf crospovidone erythrosine gelatin iron oxide yellow lactose monohydrate magnesium stearate purified water titanium dioxide - atazanavir viatris is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents, in adult patients and in paediatric patients 6 to 18 years of age. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.
atazanavir (teva)
teva pharma (new zealand) limited - atazanavir sulfate 170.872mg (equiv 150 mg atazanavir) - capsule - 150 mg - active: atazanavir sulfate 170.872mg (equiv 150 mg atazanavir) excipient: crospovidone gelatin indigo carmine lactose monohydrate magnesium stearate titanium dioxide - atazanavir is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.
atazanavir alphapharm atazanavir (as sulfate) 150 mg capsule bottle
alphapharm pty ltd - atazanavir sulfate, quantity: 170.85 mg (equivalent: atazanavir, qty 150 mg) - capsule - excipient ingredients: lactose monohydrate; crospovidone; magnesium stearate; titanium dioxide; brilliant blue fcf; purified water; iron oxide yellow; erythrosine; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - atazanavir is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies (see clinical trials).
atazanavir viatris
viatris limited - atazanavir sulfate 227.8mg equivalent to atazanavir 200mg; atazanavir sulfate 227.8mg equivalent to atazanavir 200mg - capsule - 200 mg - active: atazanavir sulfate 227.8mg equivalent to atazanavir 200mg excipient: brilliant blue fcf crospovidone erythrosine gelatin lactose monohydrate magnesium stearate purified water titanium dioxide active: atazanavir sulfate 227.8mg equivalent to atazanavir 200mg excipient: crospovidone gelatin indigo carmine iron oxide yellow lactose monohydrate magnesium stearate patent blue v purified water tekprint black sw-9008 titanium dioxide - atazanavir viatris is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents, in adult patients and in paediatric patients 6 to 18 years of age. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.
atazanavir viatris
viatris limited - atazanavir sulfate 341.7mg equivalent to atazanavir 300mg; atazanavir sulfate 341.7mg equivalent to atazanavir 300mg - capsule - 300 mg - active: atazanavir sulfate 341.7mg equivalent to atazanavir 300mg excipient: brilliant blue fcf crospovidone erythrosine gelatin iron oxide red iron oxide yellow lactose monohydrate magnesium stearate purified water titanium dioxide active: atazanavir sulfate 341.7mg equivalent to atazanavir 300mg excipient: crospovidone gelatin iron oxide red iron oxide yellow lactose monohydrate magnesium stearate patent blue v purified water tekprint black sw-9008 titanium dioxide - atazanavir viatris is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents, in adult patients and in paediatric patients 6 to 18 years of age. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.
atazanavir myl atazanavir (as sulfate) 150 mg capsule bottle
alphapharm pty ltd - atazanavir sulfate -
reyataz 200 mg
bristol - myers squibb, israel - atazanavir as sulfate - capsules - atazanavir as sulfate 200 mg - atazanavir - atazanavir - reyataz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.